NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

Iradimed Corp (NASDAQ:IRMD) issued its earnings results on Wednesday, October, 30th. The medical equipment provider reported $0.20 EPS for the quarter, beating the consensus estimate of $0.13 by $0.07. The medical equipment provider earned $9.96 million during the quarter, compared to analysts' expectations of $9.85 million. Iradimed had a net margin of 22.51% and a return on equity of 16.24%. View Iradimed's Earnings History.

Iradimed is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Iradimed.

Media stories about IRMD stock have been trending very negative this week, InfoTrie reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Iradimed earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Iradimed.

Iradimed saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 460,900 shares, an increase of 7.7% from the December 15th total of 428,000 shares. Based on an average trading volume of 67,700 shares, the short-interest ratio is currently 6.8 days. Currently, 8.5% of the shares of the company are short sold. View Iradimed's Current Options Chain.

Some companies that are related to Iradimed include Cryolife (CRY), Luminex (LMNX), Orthofix Medical (OFIX), Axonics Modulation Technologies (AXNX), Orthopediatrics (KIDS), Intersect ENT (XENT), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), MiMedx Group (MDXG), Anika Therapeutics (ANIK), Cerus (CERS), AngioDynamics (ANGO), SurModics (SRDX), SI-Bone (SIBN) and OraSure Technologies (OSUR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Palo Alto Networks (PANW), BioTelemetry (BEAT), Alphabet (GOOG), IntriCon (IIN), Micron Technology (MU), Paypal (PYPL), Alibaba Group (BABA) and Mastercard (MA).

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRMD stock can currently be purchased for approximately $26.25.

Iradimed has a market capitalization of $301.35 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

The official website for Iradimed is http://www.iradimed.com/.

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]